Supplementary Materials

The PDF file includes:

  • Materials and Methods
  • Fig. S1. Univariate humoral immune response comparisons across MAL068 vaccinees.
  • Fig. S2. Model performance in RRR vaccinees.
  • Fig. S3. Different concentrations of CSP-specific antibodies track with protection within arms.
  • Fig. S4. Model performance in ARR vaccinees.
  • Fig. S5. Performance of model separating protected from infected vaccinees, independent of vaccine arm in the MAL068 study.
  • Fig. S6. Measurement of antibody concentrations alone cannot predict protection in the MAL068 study.
  • Fig. S7. Measurement of hepatitis B virus–specific antibody concentrations cannot predict protection in the MAL068 study.
  • Fig. S8. Architecture of immune responses in individuals vaccinated with RTS,S/AS01 across studies.
  • Fig. S9. In vitro and in vivo activity of CSP-specific monoclonal antibodies.
  • References (69–91)

[Download PDF]

Other Supplementary Material for this manuscript includes the following: